Literature DB >> 6095220

Characterization of neurotensin binding to rat gastric smooth muscle receptor sites.

P Kitabgi, C Y Kwan, J E Fox, J P Vincent.   

Abstract

The binding of monoiodo 125I-Trp11-neurotensin to purified rat gastric fundus smooth muscle plasma membranes was characterized. Specific binding of ligand in subcellular fractions from rat fundus smooth muscle showed a distribution that paralleled that of several plasma membrane marker enzymes. 125I-Trp11-neurotensin binding to smooth muscle plasma membranes at 25 degrees C was maximal at 30 min, reversible and saturable. Scatchard analysis of equilibrium data indicated the existence of two classes of binding sites with dissociation constants (Kd) of 56 pmol and 1.92 nM, and corresponding binding capacities (Bmax) of 6.6 fmol/mg and 11.4 fmol/mg of membrane protein. Analogues and fragments of neurotensin competed for 125I-Trp11-neurotensin binding with a rank order of potency similar to that previously reported for their contracting effect in rat fundus strips. Na+ decreased in a concentration dependent manner the binding of labelled ligand to the high affinity site. At 100 mM, Na+ induced a 6-fold increase in the IC50 of neurotensin for inhibition of 125I-Trp11-neurotensin binding. At this concentration of Na+, the IC50 for neurotensin was 1 nM, a value close to the Kd of the low affinity site.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095220     DOI: 10.1016/0196-9781(84)90117-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Cation-induced aggregation of membrane vesicles isolated from vascular smooth muscle.

Authors:  C Y Kwan
Journal:  J Bioenerg Biomembr       Date:  1986-12       Impact factor: 2.945

2.  Gastrointestinal neurotensin receptors: contribution of the aromatic hydroxyl group in position 11 to peptide potency.

Authors:  M V Donoso; J P Huidobro-Toro; S St Pierre
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

3.  Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.

Authors:  A Schotte; J E Leysen; P M Laduron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

4.  Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

Authors:  M H Mogard; V Maxwell; B Sytnik; J H Walsh
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Regul Pept       Date:  2013-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.